Economics at your fingertips  

Pharmaceutical Antitrust Litigation in 2015—Settlements, Product Hopping and REMS

Seth Silber, Jeffrey Bank, Courtney Armour, Kellie Kemp, Brendan Coffman and Ryan Maddock

Antitrust Chronicle, 2015, vol. 12

Abstract: Discussion about what constitutes “competitive†levels of pharmaceutical prices can be heard everywhere; meanwhile, government officials, individual consumers, intermediate distributors and retailers, and, in some cases, generic pharmaceutical companies continue to turn to antitrust law as an enforcement tool. Seth C. Silber, Jeff Bank, Courtney Armour, Kellie Kemp, Brendan Coffman, & Ryan Maddock (Wilson Sonsini Goodrich & Rosati)

JEL-codes: K21 (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations: Track citations by RSS feed

Downloads: (external link) ... uct-hopping-and-rems (application/pdf)
Requires login and subscription

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link:

Access Statistics for this article

More articles in Antitrust Chronicle from Competition Policy International
Bibliographic data for series maintained by Lindsay McSweeney (). This e-mail address is bad, please contact .

Page updated 2019-04-22
Handle: RePEc:cpi:atchrn:12.1.2015:i=20754